Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

Journal of Clinical Investigation

Volumn 109, Issue 8, 2002, Pages 1057-1063

  Han, Eun D ^a   MacFarlane, Ryan C ^a   Mulligan, Aideen N ^a   Scafidi, Jennifer ^a   Davis III, Alvin E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; CAPTOPRIL; COMPLEMENT COMPONENT C1S INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DX 88; ICATIBANT; KALLIKREIN INHIBITOR; PLASMA KALLIKREIN; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; GENE DISRUPTION; HETEROZYGOSITY; HOMOZYGOSITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANGIONEUROTIC EDEMA; ANIMALS; BRADYKININ; CAPILLARY PERMEABILITY; COMPLEMENT C1 INACTIVATOR PROTEINS; DISEASE MODELS, ANIMAL; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ;

EID: 0036122075     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200214211     Document Type: Article

References (25)

1. Interaction of 125I-labeled complement components C1r and C1s with protease inhibitors in plasma
2. The inhibition of plasmin, plasma kallikrein, plasma permeability, factor, and the C'1r subcomponent of complement by serum C'1 esterase inhibitor
3. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified C1 inactivator
4. Interaction of plasma kallikrein with the C1 inhibitor
5. Inhibition by C1INH of Hageman factor fragment activation of coagulation, fibrinolysis, and kinin generation
6. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: Major role for C1-inhibitor
7. C1s-induced vascular permeability in C2-deficient guinea pigs
8. Angioedema induced by a peptide derived from complement component C2.J
9. Hereditary angioneurotic edema: Characterization of plasma kinin and vascular permeability-enhancing activities
10. 443→Val substitution and functional analysis of the recombinant mutant protein
11. Plasma bradykinin in angio-oedema
12. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells
13. Insertional mutagenesis by rectoviruses and promoter traps in embryonic stem cells
14. Gene and enhancer crap screens in ES cell chimeras
15. Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin actions in smooth muscle and neurons
16. Molecular cloning, gene structure and expression profile of mouse C1 inhibitor
17. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
18. Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombin
19. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma
20. Effect of C'1 esterase on vascular permeability in man: Studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema
21. Kinin formation in hereditary angioedema plasma: Evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin
22. Cleavage of the second component of complement by plasma proteases: Implications in hereditary C1inhibitor deficiency
23. Detection of active kallikrein in induced blister fluids of hereditary angioedema patients
24. New synthetic antagonists of bradykinin
25. Analysis of the receptors mediating the vascular actions of bradykinin